Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
2,89 USD | +1,23% | -16,71% | -9,97% |
Attività
Numero di dipendenti: 233
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Allogeneic T Cell Therapies
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | -60,91% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | -60,91% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Joshua Kazam
FOU | Founder | 47 | 01/11/17 |
David Chang
FOU | Founder | 64 | 01/04/18 |
Geoffrey Parker
DFI | Director of Finance/CFO | 59 | 16/10/23 |
Lillian Smith
CMP | Compliance Officer | 52 | 01/04/23 |
Zachary Roberts
CTO | Chief Tech/Sci/R&D Officer | 46 | 03/01/23 |
Timothy Moore
CTO | Chief Tech/Sci/R&D Officer | 62 | 01/04/23 |
Earl Douglas
CMP | Compliance Officer | 61 | 14/08/23 |
Jack Chen
AUD | Comptroller/Controller/Auditor | - | - |
Human Resources Officer | 58 | 02/05/22 | |
General Counsel | - | 01/03/18 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
David Bonderman
BRD | Director/Board Member | 81 | 01/05/18 |
Joshua Kazam
FOU | Founder | 47 | 01/11/17 |
Arie Belldegrun
FOU | Founder | 74 | 01/11/17 |
Vicki Sato
BRD | Director/Board Member | 75 | 30/07/21 |
Todd Sisitsky
BRD | Director/Board Member | 52 | 01/04/18 |
Stephen Mayo
BRD | Director/Board Member | 62 | 12/07/22 |
Director/Board Member | 62 | 30/07/21 | |
Deborah Messemer
BRD | Director/Board Member | 66 | 28/09/18 |
Owen N. Witte
BRD | Director/Board Member | 74 | 01/04/18 |
David Chang
FOU | Founder | 64 | 01/04/18 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 170 723 100 | 114 078 167 ( 66,82 %) | 0 | 66,82 % |
Coordinate società
Allogene Therapeutics, Inc.
210 East Grand Avenue
94080-4811, South San Francisco
+
http://www.allogene.comSettore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-9,97% | 493 Mln | |
-2,31% | 103 Mrd | |
+0,56% | 95,28 Mrd | |
+1,69% | 22,15 Mrd | |
-17,37% | 21,02 Mrd | |
-9,30% | 18,15 Mrd | |
-41,01% | 16,73 Mrd | |
-14,85% | 16,05 Mrd | |
+3,21% | 13,68 Mrd | |
+33,54% | 12,17 Mrd |
- Borsa valori
- Azioni
- Azione ALLO
- Società Allogene Therapeutics, Inc.